ESS
47
7
WU
38
-9
VTR
69
2
GT
39
-3
PRGO
43
4
ACN
54
-2
M
53
-5
SCHW
67
3
DUK
55
3
IFF
59
2
IRM
44
3
RIG
43
3
CMS
60
2
EA
44
-3
FITB
78
3
TXN
52
2
ROP
42
4
KMI
63
10
KO
46
2
PSX
25
-12
ESS
47
7
WU
38
-9
VTR
69
2
GT
39
-3
PRGO
43
4
ACN
54
-2
M
53
-5
SCHW
67
3
DUK
55
3
IFF
59
2
IRM
44
3
RIG
43
3
CMS
60
2
EA
44
-3
FITB
78
3
TXN
52
2
ROP
42
4
KMI
63
10
KO
46
2
PSX
25
-12
Financhill
Back

Global X NASDAQ 100 Covered Call ETF Vs. Oruka Therapeutics, Inc. Sector Stock Comparison

Buy
60

QYLD
Global X NASDAQ 100 Covered Call ETF

Last Price:
$17.67
Seasonality Move:
-3.16%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
60
Global X NASDAQ 100 Covered Call ETF (QYLD) is a Buy

Is Global X NASDAQ 100 Covered Call ETF a Buy, Sell or Hold?

  • The current Global X NASDAQ 100 Covered Call ETF [QYLD] share price is $17.66. The Score for QYLD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • QYLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QYLD Stock Price Chart

What is Global X NASDAQ 100 Covered Call ETF's stock price today?

  • The Global X NASDAQ 100 Covered Call ETF share price today is $17.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLD is experiencing selling pressure, which indicates risk of future bearish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

QYLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.93 Buy
Relative Strength Index (14 RSI): 62.89 Buy
Chaikin Money Flow: -4614644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.36 - 17.62) Buy
Bollinger Bands (100): (16.82 - 17.46) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

QYLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.6 Buy
20-day SMA: 17.53 Buy
50-day SMA: 17.42 Buy
200-day SMA: 16.83 Buy
8-day EMA: 11.19 Buy
20-day EMA: 5.82 Buy
50-day EMA: 2.61 Buy
200-day EMA: 0.69 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Global X NASDAQ 100 Covered Call ETF Earnings Growth & QYLD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Global X NASDAQ 100 Covered Call ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):